RAPS: FDA Outlines New Communication Process for Generic Drug Companies
28.08.2014
The US Food and Drug Administration (FDA) is out with its fourth draft guidance document under the 2012 Generic Drug User Fee Act, this time explaining the nuances of how generic drug companies can submit requests for information from the agency.
SciencePharma
